Clinical and molecular genetic analysis of a family with late-onset LAMA2-related muscular dystrophy

详细信息    查看全文

• 作者：Juan Ding^a ; Dandan Zhao^b ; Renqian Du^c ; Yuehua Zhang^a ; Haipo Yang^a ; Jieyu Liu^a ; Chuanzhu Yan^b ; Feng Zhang^c ; Hui Xiong^a ; ^{xh_bjbj@163.com" class="auth_mail" title="E-mail the corresponding author}
• 关键词：LAMA2 ; Limb-girdle muscular dystrophy ; The next generation sequencing ; Multiplex ligation dependent probe amplification ; Array comparative genomic hybridization
• 刊名：Brain and Development
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：38
• 期：2
• 页码：242-249
• 全文大小：2603 K

文摘

LAMA2-related muscular dystrophy (LAMA2 MD) is an autosomal recessive inherited disease caused by LAMA2 gene mutation. The spectrum of the phenotype is expanding in recent years partially due to the definitive diagnosis of molecular genetics. We investigated the phenotype and genotype in a LAMA2 MD family manifesting as limb-girdle muscular dystrophy (LGMD).

Methods

The clinical information of the proband and his family was collected. Muscle biopsy and immunohistochemical staining for the muscle specimen were performed. The genomic DNA of the family was extracted from the peripheral blood, and genetic testing was analyzed using the next generation sequencing and multiplex ligation dependent probe amplification (MLPA). The point mutation was verified by Sanger sequencing while exonic deletion was verified by array comparative genomic hybridization.

Results

The patient had mild motor retardation when he was young, and no obvious weakness was reported. Muscle biopsy showed mild atrophy in histochemical staining. Immunohistochemical staining using antibody against merosin showed nearly normal expression surrounding the muscle fiber. The proband’s sister had similar symptoms. By analyzing the gene test we found that compound heterozygous LAMA2 mutation inherited from the parents respectively. One coming from the father was a gross deletion expanding from exon 36 to exon 65. The other from the mother was a missense mutation c.1358G>C (p.Cys453Ser). Sanger sequencing verified the point mutation. Array comparative genomic hybridization confirmed a long stretch of deletion about 27.6–34.7 kb. The sister had the same mutations as the proband. We diagnosed the first late onset LAMA2 MD Chinese patients on molecular level and genetic counseling is available.

Conclusion

We investigated the phenotype and genotype in a family manifesting as limb-girdle muscular dystrophy (LGMD). This LAMA2 MD family manifesting as LGMD was identified in molecular genetic level and their phenotypes was described.